Retrotope, Inc.
Records under this name other than the patents Retrotope, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,320,289 | Isotopically Modified Compounds and Their Use as Food Supplements Formerly held In force · High confidence | In force | High confidence | |
| US 9,616,042 | Isotopically Modified Compounds and Their Use as Food Supplements Formerly held In force · High confidence | In force | High confidence | |
| US 10,015,979 | Isotopically Modified Compounds and Their Use as Food Supplements Formerly held In force · High confidence | In force | High confidence | |
| US 10,918,126 | Isotopically Modified Compounds and Their Use as Food Supplements Formerly held In force · High confidence | In force | High confidence | |
| US 8,637,486 | Therapeutic substances that modulate genome methylation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,906,405 | Isotopically Modified Compounds and Their Use as Food Supplements Formerly held In force · High confidence | In force | High confidence | |
| US 10,058,522 | Oxidative Retinal Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 10,058,612 | Impaired energy processing disorders and mitochondrial deficiency Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,154,978 | Disorders implicating PUFA oxidation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,154,983 | Neurodegenerative disorders and muscle diseases implicating PUFAs Formerly held In force · From the USPTO record | In force | From the USPTO record |